Adezmapimod

Adezmapimod
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T1764-5mg 5 mg

7 - 10 business days*

30.00€
TGM-T1764-10mg 10 mg

7 - 10 business days*

45.00€
TGM-T1764-1mL 1 ml

7 - 10 business days*

48.00€
TGM-T1764-50mg 50 mg

7 - 10 business days*

60.00€
TGM-T1764-100mg 100 mg

7 - 10 business days*

95.00€
TGM-T1764-200mg 200 mg

7 - 10 business days*

163.00€
TGM-T1764-500mg 500 mg

7 - 10 business days*

275.00€
 
Description: Adezmapimod (SB 203580) is a selective, ATP-competitive p38 MAPK inhibitor... more
Product information "Adezmapimod"
Description: Adezmapimod (SB 203580) is a selective, ATP-competitive p38 MAPK inhibitor (IC50=0.3-0.5 µM) that activates autophagy and mitochondrial autophagy, with more than 100-fold higher selectivity over PKB, LCK, and GSK-3beta. Target: Autophagy, p38 MAPK, Mitophagy. Smiles: FC1=CC=C(C2=C(N=C(N2)C3=CC=C(S(C)=O)C=C3)C=4C=CN=CC4)C=C1. References: Henklova P, et al. SB203580, a pharmacological inhibitor of p38 MAP kinase transduction pathway activates ERK and JNK MAP kinases in primary cultures of human hepatocytes. Eur J Pharmacol. 2008 Sep 28,593(1-3):16-23.
Keywords: SB203580, PB 203580, RWJ 64809
Supplier: TargetMol
Supplier-Nr: T1764

Properties

Application: p38 MAP kinase inhibitor
MW: 377.43 D
Formula: C21H16FN3OS

Database Information

CAS : 152121-47-6| Matching products
KEGG ID : K04368 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Signal Word: Danger
GHS Hazard Pictograms:
H Phrases: H302, H318
P Phrases: P264, P270, P280, P301+310, P305+351+338, P310, P330, P501
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Adezmapimod"
Write a review
or to review a product.
Viewed